FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2885676567> ?p ?o ?g. }

• W2885676567 endingPage "1377" @default.
• W2885676567 startingPage "1369" @default.
• W2885676567 abstract "Adjunctive lacosamide treatment for adult focal-onset epilepsy: focus on comorbid intellectual/developmental disorders and differing responses Ebru Apaydin Doğan,1 Umuttan Doğan,2 Emine Genç,3 Çağla Erdoğan,1 Bülent Oğuz Genç3 1Department of Neurology, School of Medicine, Akdeniz University, Antalya, Turkey; 2Department of Cardiology, School of Medicine, Akdeniz University, Antalya, Turkey; 3Department of Neurology, School of Medicine, Necmettin Erbakan University, Konya, Turkey Background: Data regarding lacosamide treatment as an adjunctive therapy in patients representative of a focal-onset epilepsy population including those with and without intellectual/developmental disorders (IDDs) are limited. Purpose: To evaluate the retention rates of lacosamide in focal-onset epilepsy patients with and without IDD. Patients and methods: We retrospectively reviewed all consecutive electronic and paper medical records of patients diagnosed with focal-onset epilepsy who were treated with lacosamide in two tertiary epilepsy centers. Results: One hundred and thirty-six patients who met the inclusion criteria were studied. Number of patients with IDD was 46 (33.8%). Median lacosamide dose was 300 mg/day. A total of 39 patients (28.7%) experienced side effects, and 22 of them (16.2%) discontinued lacosamide. The 1-, 2-, and 3-year retention rates of lacosamide in patients with IDD were 68%, 62%, and 53%, respectively. Kaplan–Meier survival analysis showed that the retention rates were significantly lower in patients with IDD when compared to patients without IDD (P=0.04). Cox regression analysis showed that concomitant use of sodium channel blocker antiepileptic drugs (AEDs) was the only independent predictor of retention rate of lacosamide treatment (P=0.03). In the subgroup of patients with IDD, the analysis was performed again and the number of background AEDs was the only predictor for the retention rate of lacosamide (P=0.04). Conclusion: When compared to patients without IDD, retention rates of lacosamide adjunctive therapy were lower in patients with IDD. However, these rates were higher than the rates suggested with previously registered AEDs including lamotrigine, levetiracetam, and topiramate. Therefore, irrespective of having comorbid IDD, we might suggest that lacosamide is a well-retained drug with a high efficacy profile in patients with focal-onset epilepsy. Keywords: lacosamide, focal-onset epilepsy, intellectual/developmental disorders" @default.
• W2885676567 created "2018-08-22" @default.
• W2885676567 creator A5007361161 @default.
• W2885676567 creator A5029395324 @default.
• W2885676567 creator A5032307163 @default.
• W2885676567 creator A5071097128 @default.
• W2885676567 creator A5078681370 @default.
• W2885676567 date "2018-08-01" @default.
• W2885676567 modified "2023-09-26" @default.
• W2885676567 title "Adjunctive lacosamide treatment for adult focal-onset epilepsy: focus on comorbid intellectual/developmental disorders and differing responses" @default.
• W2885676567 cites W19492624 @default.
• W2885676567 cites W1979093403 @default.
• W2885676567 cites W1990930845 @default.
• W2885676567 cites W2016374115 @default.
• W2885676567 cites W2017493593 @default.
• W2885676567 cites W2018032934 @default.
• W2885676567 cites W2022458589 @default.
• W2885676567 cites W2052571884 @default.
• W2885676567 cites W2053113481 @default.
• W2885676567 cites W2057685654 @default.
• W2885676567 cites W2064506142 @default.
• W2885676567 cites W2065058324 @default.
• W2885676567 cites W2127571361 @default.
• W2885676567 cites W2128726239 @default.
• W2885676567 cites W2169137352 @default.
• W2885676567 cites W2417095403 @default.
• W2885676567 cites W2464530588 @default.
• W2885676567 cites W2494172419 @default.
• W2885676567 cites W2497588579 @default.
• W2885676567 cites W2586251712 @default.
• W2885676567 cites W2616137279 @default.
• W2885676567 cites W2618890328 @default.
• W2885676567 cites W2745781832 @default.
• W2885676567 cites W2761487903 @default.
• W2885676567 cites W2790913305 @default.
• W2885676567 cites W311067477 @default.
• W2885676567 cites W641823132 @default.
• W2885676567 doi "https://doi.org/10.2147/tcrm.s171793" @default.
• W2885676567 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6080872" @default.
• W2885676567 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30122936" @default.
• W2885676567 hasPublicationYear "2018" @default.
• W2885676567 type Work @default.
• W2885676567 sameAs 2885676567 @default.
• W2885676567 citedByCount "3" @default.
• W2885676567 countsByYear W28856765672019 @default.
• W2885676567 countsByYear W28856765672020 @default.
• W2885676567 countsByYear W28856765672021 @default.
• W2885676567 crossrefType "journal-article" @default.
• W2885676567 hasAuthorship W2885676567A5007361161 @default.
• W2885676567 hasAuthorship W2885676567A5029395324 @default.
• W2885676567 hasAuthorship W2885676567A5032307163 @default.
• W2885676567 hasAuthorship W2885676567A5071097128 @default.
• W2885676567 hasAuthorship W2885676567A5078681370 @default.
• W2885676567 hasBestOaLocation W28856765671 @default.
• W2885676567 hasConcept C118552586 @default.
• W2885676567 hasConcept C126322002 @default.
• W2885676567 hasConcept C16568411 @default.
• W2885676567 hasConcept C187212893 @default.
• W2885676567 hasConcept C195910791 @default.
• W2885676567 hasConcept C2778139780 @default.
• W2885676567 hasConcept C2778186239 @default.
• W2885676567 hasConcept C2908647359 @default.
• W2885676567 hasConcept C71924100 @default.
• W2885676567 hasConcept C99454951 @default.
• W2885676567 hasConceptScore W2885676567C118552586 @default.
• W2885676567 hasConceptScore W2885676567C126322002 @default.
• W2885676567 hasConceptScore W2885676567C16568411 @default.
• W2885676567 hasConceptScore W2885676567C187212893 @default.
• W2885676567 hasConceptScore W2885676567C195910791 @default.
• W2885676567 hasConceptScore W2885676567C2778139780 @default.
• W2885676567 hasConceptScore W2885676567C2778186239 @default.
• W2885676567 hasConceptScore W2885676567C2908647359 @default.
• W2885676567 hasConceptScore W2885676567C71924100 @default.
• W2885676567 hasConceptScore W2885676567C99454951 @default.
• W2885676567 hasLocation W28856765671 @default.
• W2885676567 hasLocation W28856765672 @default.
• W2885676567 hasLocation W28856765673 @default.
• W2885676567 hasLocation W28856765674 @default.
• W2885676567 hasOpenAccess W2885676567 @default.
• W2885676567 hasPrimaryLocation W28856765671 @default.
• W2885676567 hasRelatedWork W2584059828 @default.
• W2885676567 hasRelatedWork W2599353587 @default.
• W2885676567 hasRelatedWork W2778132151 @default.
• W2885676567 hasRelatedWork W2805536053 @default.
• W2885676567 hasRelatedWork W2905011092 @default.
• W2885676567 hasRelatedWork W3182709878 @default.
• W2885676567 hasRelatedWork W4232290174 @default.
• W2885676567 hasRelatedWork W4256640757 @default.
• W2885676567 hasRelatedWork W4327617781 @default.
• W2885676567 hasRelatedWork W4380869779 @default.
• W2885676567 hasVolume "Volume 14" @default.
• W2885676567 isParatext "false" @default.
• W2885676567 isRetracted "false" @default.
• W2885676567 magId "2885676567" @default.
• W2885676567 workType "article" @default.